MedPage Today: Treatment Costs Doubled for Patients With Psoriasis Who Take Biologics
For patients with plaque psoriasis who initiated treatment with a first-line biologic, the average treatment cost more than doubled from 2007 to 2021 as more patients started newer IL-17 and IL-23 ...
Medscape: Dermatologists, Rheumatologists, and Patients Debate the Role of GLP-1 Drugs in Psoriasis and Psoriatic Arthritis
Dermatologists, Rheumatologists, and Patients Debate the Role of GLP-1 Drugs in Psoriasis and Psoriatic Arthritis
Many patients struggle with therapeutic control, adverse effects, and costs of psoriasis treatments, prompting a renewed focus on alternative treatments like phototherapy. “The LITE study provides ...
Seeking Alpha: Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp and genital psoriasis
66% of patients with scalp psoriasis and 77% with genital psoriasis treated with investigational icotrokinra achieved site-specific clear or almost clear skin at Week 16 Icotrokinra continues to ...
Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp and genital psoriasis
Philip Mease, MD, discusses the different treatment options now available for patients with psoriasis and psoriatic arthritis. Psoriatic arthritis (PsA) affects roughly 30% of patients with psoriasis, ...
News Medical: Residual inflammation can linger in psoriasis patients despite skin treatment
New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity ...
In areas of high impact, 72% of patients with scalp psoriasis and 85% with genital psoriasis treated with icotrokinra achieved site-specific clear or almost clear skin at Week 52 in Phase 3 ...
(Paris, France, Thursday, 18 September 2025) Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major ...
The American Journal of Managed Care: Patients, Providers Strongly Favor Oral Therapies in Psoriasis
Psoriasis significantly impacts quality of life, affecting sleep and mental health, with a high prevalence of comorbidities. The ENCOMPASS study surveyed patients and dermatologists, highlighting ...
Biologic therapies demonstrated comparable safety to conventional systemic agents in patients with psoriasis who had active cancer or recent cancer history, with similar progression and recurrence ...
Biologic drugs used to treat psoriasis were associated with lower risks for certain ocular diseases, including keratitis and dry eye disease, in a large-scale analysis published in Eye.“Given the ...
Please provide your email address to receive an email when new articles are posted on . The majority of patients and clinicians agreed with the use of as-needed biologic therapy for psoriasis.
MedPage Today: Adherence Strategies to Help for Psoriasis (and All) Patients That Might Actually Work
The authors of a new review in Dermatologic Clinics focus on the challenge of patient adherence to psoriasis treatment and offer interventions to overcome barriers to adherence. Better adherence can ...
Adherence Strategies to Help for Psoriasis (and All) Patients That Might Actually Work
The American Journal of Managed Care: Home-Based Phototherapy for Psoriasis as Effective as Office-Based Treatment With Less Patient Burden
Home-Based Phototherapy for Psoriasis as Effective as Office-Based Treatment With Less Patient Burden
MedPage Today: Scalp Psoriasis: 10 Ways to Reduce Hair Loss -- A Guide for Patients
Scalp Psoriasis: 10 Ways to Reduce Hair Loss -- A Guide for Patients
The American Journal of Managed Care: Tailoring Psoriasis, Psoriatic Arthritis Treatment to the Patient: Philip Mease, MD
Most patients are diagnosed at a far less treatable, later stage of the disease. And with about 20% of lung cancer deaths preventable, evidence-based screening recommendations for high-risk patients offer the best hope to catch the disease early and provide the best chance for effective treatment. A medical oncologist shares more.
Nasdaq: New study reveals substantial unmet need in psoriasis, shows strong patient and provider preference for highly effective oral treatments with favorable safety profile
Findings highlight opportunity for shared decision-making to improve treatment planning, with more than 90% of patients currently on injectables willing to switch to a new oral therapy with equivalent ...
New study reveals substantial unmet need in psoriasis, shows strong patient and provider preference for highly effective oral treatments with favorable safety profile
Everyday Health on MSN: Rotational therapy in psoriasis treatment: What you need to know
EurekAlert!: GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients
clinicaladvisor.com: Biologics for Psoriasis Are Safe in Patients With Recent or Active Cancer
Biologic and conventional therapies were associated with comparable rates of cancer progression and recurrence among patients with psoriasis who have active cancer or who have had cancer within 5 ...
Biologics for Psoriasis Are Safe in Patients With Recent or Active Cancer
Medscape: Exercise Found to Slash Psoriatic Arthritis Risk in Patients With Psoriasis
Stay on top of the latest developments related to patient education. Browse the AMA’s patient education resources, full of information and tools that physicians can share with their patients, including educational handouts for patients and other patient education materials.
For this installment, three AMA members took time to discuss what doctors wish patients knew about the potentially harmful effects of social media. They are: Nusheen Ameenuddin, MD, MPH, a pediatrician in Rochester, Minnesota, and chair of the American Academy of Pediatrics Council on Communications and Media.
The discussion was moderated by William B. Jordan, MD, MPH, who is senior director of equity policy and transformation at the AMA Center for Health Equity. Panelists examined the quality of care older-adult physicians provide, how age-related biases affect older-adult physicians, and how ageism affects patients’ care experience.
The AMA’s What Doctors Wish Patients Knew ™ series gives physicians a platform to share what they want patients to understand about today’s health care headlines and how to take charge of their health through preventive care.
Getting patients to make healthy lifestyle choices ranks high on every physician’s professional wish list. But realistically accomplishing this goal requires care teams to zero in on what really patients really want.
The AMA’s What Doctors Wish Patients Knew ™ series gives physicians a platform to share what they want patients to understand about today’s health care headlines. Three physicians took time to discuss what doctors wish patients knew about vitamins and nutritional supplements. They are: Pieter Cohen, MD, an internist in Somerville ...